Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 10Phase 3 3Phase 4 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 8Unknown 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Genitourinary 1

Conditions

Breast Neoplasms 55Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 13Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Gastrointestinal Stromal Tumors × Clear all
NCT00274885 2011-12-05

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

National Cancer Institute (NCI)

Phase 4 Unknown
58 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neurotoxicity Syndromes, Gastrointestinal Stromal Tumors

NCT00777504 2011-09-16

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

Radboud University Medical Center

Phase 4 Unknown
30 enrolled
GastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡